PD Dr. Matthias Rübner

Department of Obstetrics and Gynaecology Medizinische Fakultät

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy (2021) Reimann H, Nguyen A, Sanborn JZ, Vaske CJ, Benz SC, Niazi K, Rabizadeh S, et al. Journal article Shifts in Macrophage as a prognostic Biomarker in Patients with luminal Breast Cancer - A Confirmatory Study (2021) Schnellhardt S, Segelhorst S, Erber R, Daniel C, Hartmann A, Fasching P, Beckmann M, et al. Conference contribution Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis (2021) Fasching P, Yadav S, Hu C, Wunderle M, Häberle L, Hart SN, Rübner M, et al. Journal article NGS zur Selektion innovativer Therapien – Was bringt das? (2021) Schulmeyer C, Bader S, Hübner H, Rübner M, Fasching P Journal article, Review article Placental thromboinflammation impairs embryonic survival by reducing placental thrombomodulin expression (2021) Kohli S, Singh KK, Gupta A, Markmeyer P, Lochmann F, Gupta D, Rana R, et al. Journal article Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program (2021) Muller V, Banys-Paluchowski M, Friedl TWP, Fasching P, Schneeweiss A, Hartkopf A, Wallwiener D, et al. Journal article Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis (2021) Hübner H, Lubrich H, Blum S, Antoniadis S, Lermann J, Ekici AB, Fasching P, et al. Journal article Association of genomic variants at PAX8 and PBX2 with cervical cancer risk (2021) Ramachandran D, Wang Y, Schuermann P, Huelse F, Mao Q, Jentschke M, Boehmer G, et al. Journal article Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany (2020) Hübner H, Kurbacher CM, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Journal article HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment (2020) Würfel F, Hübner H, Häberle L, Gaß P, Hein A, Jud S, Hack C, et al. Journal article